Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study
Mohammad E. Naffaa, Fadi Hassan, Avivit Golan‐Cohen, Eugene Merzon, Ilan Green, Amir Saab, Ziv Paz
Topics & Concepts
MedicineEtanerceptGolimumabInternal medicineAdalimumabRheumatoid arthritisHazard ratioInfliximabTocilizumabPopulationRheumatologyRetrospective cohort studyCohortOdds ratioConfidence intervalDiseaseEnvironmental healthRheumatoid Arthritis Research and TherapiesChronic Lymphocytic Leukemia ResearchAutoimmune and Inflammatory Disorders Research